Hepaphor (Bifidobacterium bifidum, Limosilactobacillus fermentum) capsules
21623USD

Hepaphor (Bifidobacterium bifidum, Limosilactobacillus fermentum) capsules

SKU:1784
To favorites
Hepaphor (Bifidobacterium bifidum, Limosilactobacillus fermentum) combined multicomponent drug of hepatoprotective action, prevention of damage to the membranes of liver cells, suppression of pathological immune activation and inflammation
Active substance:Bifidobacterium bifidum, Limosilactobacillus fermentum
Pharmacological group:Probiotics and Prebiotics
Formulation:Capsules
Country of origin:Russia
In stock
$16
11
Description
Features
Reviews

Instructions for Hepaphor (Bifidobacterium bifidum, Limosilactobacillus fermentum) capsules

Features:

Method of use Oral Hepaphor

Pack quantity 30 pcs

Release form Capsules
Country of manufacture Russia

Active substance LactobacteriRastoropshi dry extract Bifidobacterium bifidum
Scope Hepatology

Pharmacological group G03BA 3-Oxoandrosten Derivatives
Registered as Medicinal agent
Application instructions

Active substances Hepaphor
Rastoropshi dry extract + Bifidobacteria + Lactobacteria

Release form

Capsules

Composition Hepaphor:

1 caps. contains dry extract of castor (silimar) 0.1 gAuxiliary substances: silicon dioxide colloidal - 0.1-1 mg, magnesium stearate - 0.4-4 mg, corn starch - up to 105 mg.
Capsule shell composition: titanium dioxide (white color) - 2%, iron oxide (yellow color) - 0.05-1.8%, gelatin - 96 mg.1 caps. contains Bifidobacterium bifidum (silicon-sorbed colloidal dioxide)not less than 50 million COELactobacillus fermentum (silicon-sorbed colloidal dioxide)not less than 50 million COEs: silicon dioxide colloidal - 0.6 mg, magnesium stearate - 1-10 mg, lactulose - up to 0.2 g.

Testimony Hepaphor:

  • The inventive method consists in using a hepatitis for adults of all age groups in a complex therapy for treating toxic liver
  • lesions (including medicinal ones), acute and chronic hepatitis,
  • including medicinal hepatitis (including those developed on the basis of the use of anti-tuberculosis agents) and for
  • recovering intestinal normoflora,
  • chronic hepatitis of different etiology,
  • including the bile tract dysfunction,
  • liver cirrhosis,
  • post-hepatitis conditions and acute viral hepatitis.

Method of use and doses Hepaphor:

For the treatment of toxic liver lesions, chronic hepatitis, cirrhosis of the liver, conditions after the transmissible hepatitis, medicinal hepatitis and intestinal dysbacteriosis against the background of the use of anti-tuberculosis and other antimicrobial agents - two capsules three times a day, the course of 14 - 30 days
For the treatment of acute viral hepatitis - one capsule of Hepafor three times a day, a course of 15 days.
The prophylactic preparation is used for 1-2 capsules 3 times a day, a course of 14-30 days.
If necessary, the course of the preparation is repeated after 1-3 months.
They are taken inside during meals, washed with boiling water at room temperature.

Pharmacological effect:

the drug is combined and multicomponent hepatoprotective action. Prevention of damage to liver cell membranes, suppression of free radical reactions and lipid peroxidation processes, suppression of pathological immune activation and inflammation. The liver and microflora of the gastrointestinal tract are the two main organs of detoxification, protecting the macroorganism from toxic compounds through oxidative reactions (liver) and hydrolytic reducing anaerobic processes (intestinal microflora).

Features
Active substance
Pharmacological group
Formulation
Country of origin
Brand
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating